We discussed this a while back - and there were problems. Mainly around size of RBC / Aborogen and no of shareholders
NASDAQ rules included (mix of match):
- Pre tax earnings of $11m over the past three years
- $27.5m in cash flow over each of past 3 years
- Market cap of $550m (which could be reduced)
Essentially RBC needs to get "bigger" before an alternative listing can be seriously considered.
Bookmarks